Navigation Links
PRA Holdings Announces Proposed Private Offering of $375 Million Senior Notes Due 2023
Date:9/11/2013

RALEIGH, N.C., Sept. 11, 2013 /PRNewswire/ -- PRA Holdings, Inc. ("PRA"), a leading global contract research organization providing outsourced clinical development services to the biotechnology and pharmaceutical industries, announced today that Pinnacle Merger Sub, Inc., which will be merged with and into PRA Holdings, Inc. upon consummation of the offering, intends, subject to market and other conditions, to offer $375,000,000 aggregate principal amount of its Senior Notes due 2023 (the "Notes") in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Notes will be guaranteed on a senior basis by all of PRA's existing and future direct and indirect domestic subsidiaries that guarantee obligations under its senior secured credit facilities. This offering is expected to be made in connection with the proposed acquisition of PRA and RPS Parent Holding Corp. ("RPS"), a leading global contract research organization providing clinical development services to the biotechnology and pharmaceutical industry, by entities affiliated with Kohlberg Kravis Roberts & Co. L.P. (the "Sponsor"). The net proceeds from this offering will be used to finance in part the acquisition of PRA and RPS by the Sponsor, the repayment of existing debt of PRA and RPS and the payment of fees and expenses in connection with such transactions.

The Notes and the related guarantees will be offered only to qualified institutional buyers in reliance on the exemption from registration set forth in Rule 144A under the Securities Act, and outside the United States to non-U.S. persons in reliance on the exemption from registration set forth in Regulation S under the Securities Act. The Notes and the related guarantees have not been registered under the Securities Act, or the securities laws of any state or other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from the Securities Act and applicable state securities or blue sky laws and foreign securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, any securities, nor shall there be any sales of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


'/>"/>
SOURCE PRA Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
2. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
3. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
4. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
5. Accident Fund Holdings Aims to Improve Control of Drug Utilization and Quality of Care with Change in Pharmacy Benefit Manager
6. China Kanghui Holdings Reports First Quarter 2012 Financial Results
7. InfuSystem Holdings Modifies Bylaws to Align with Corporate Governance Best Practices
8. InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan
9. Golden Meditech Holdings Limited Announces 2011/ 2012 Annual Results
10. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 Third Quarter Earnings Conference Call and Webcast
11. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016  The blood testing market ... dollars, according to Kalorama Information and The Freedonia Group ... and nucleic acid testing.  The healthcare research firm said ... in developing blood collection stations and in improving testing ... Kalorama Information,s report, Blood Testing Market in ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... ... flexibility in repaying their loans, more information about their loan terms and accounts, ... outstanding student loan debt, including federal and private loans, has reached $1.3 trillion, ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
Breaking Medicine News(10 mins):